Guideline / position statementindependent cross-checkabstract only checked I-ORG-03 standard review
US task force: do not screen healthy adults for thyroid cancer
Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.
Overview
US Preventive Services Task Force. JAMA 2017 · PMID 28492905 · DOI 10.1001/jama.2017.4011
Screening does more harm than good because it finds many harmless cancers.
Does the study support the specific claim? Yes · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Screening policy
- How was the study done?
Guideline
- How many people, animals or samples were studied?
n/a
- What was actually found?
Net harm
- How large was the observed effect?
D recommendation
- What do the results mean in everyday life?
Avoid screening without symptoms
- What are the study's limitations?
Indirect evidence
- What does it say about Elawady's specific claim?
Supports overdiagnosis claim
- Do the results apply to Germany and Europe?
Applicable
- What can explicitly not be concluded from this study?
Management of symptomatic nodules
Scientific in-depth review
1. Full reference
- Authors
- US Preventive Services Task Force
- Journal
- JAMA
- Year
- 2017
- Identifier
- PMID 28492905 DOI 10.1001/jama.2017.4011
- Verification
- verified – PubMed efetch 2026-10-25
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
not stated in abstract
2. Research question
Screening asymptomatic adults for thyroid cancer
3. Study design and population
- Study design
- Guideline / position statement – Evidence-based recommendation statement
- Country
USA
4. Methods and endpoints
5. Actual results
- Results
Incidence rose 4.5%/year over 10 years without change in mortality; 5-year survival 98.1%. Benefits of screening bounded as no greater than small; harms at least moderate; net benefit negative. 'Apparent lack of difference in outcomes between patients who are treated vs monitored (for the most common tumor types)'.
- Absolute risks
not reported
- Authors' conclusion
Recommends against screening for thyroid cancer in asymptomatic adults (D).
6. Strengths
- Systematic evidence review
7. Weaknesses
- Indirect evidence
8. Risk of bias
- Orienting tool
- none applicable
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- not assessable
9. Assessment of the statistical interpretation
10. Relevance to the specific claim
Supports C-ORG-14 and partly C-ORG-15 (monitoring of low-risk tumours).
11. Independent contrary findings
12. Transferability to Germany and Europe
Consistent with European practice (not verified here).
13. Overall methodological judgement
Authoritative support.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | not assessable |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | moderate |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- Thyroid cancer diagnoses tripled (US 1975-2009) while mortality stayed flat — an epidemic of diagnosis (overdiagnosis), driving avoidable thyroid surgery. – Studies supporting the claim
- No working organ should be removed (e.g., a thyroid with nodules that still functions); one should stay away from the scalpel, and Elawady is 'against any operation, including caesarean section'. – Studies supporting the claim